DCRI Impact Report | DCRI Impact Report

Adrian Hernandez, MD, MHS - DCRI Executive Director

Shining the way forward in equitable, innovative clinical research

At the DCRI, we’re bringing creative solutions to the world’s most vexing health problems. Throughout our 2022 Impact Report, you’ll learn more about the dedication of our people — more than 700 faculty and staff members — and their commitment to improving health through innovative clinical research.

In 2022, we addressed some of the most pressing questions related to:

the COVID-19 pandemic
chronic health conditions
health equity, diversity, and inclusion.

Highlighting our greatest asset — Our exceptional team members

Daniel Benjamin, MD, PhD, MPH - DCRI Deputy Director

DCRI Shine — the Duke Clinical Research Institute’s 2022 Impact Report — shines a light on the crucial questions that we’ve asked and answered over the last year. DCRI Deputy Director Danny Benjamin shares a message of gratitude to the team members who deliver thoughtful, innovative research, helping to transform healthcare each day.

Daniel Benjamin, MD, PhD, MPH - DCRI Deputy Director

Transforming

We shine by doing game-changing research that improves health outcomes

At the DCRI, innovation is at the heart of our research. Our research teams continue to find new ways to improve treatment methods and access to care. As we share our evidence and expert insights, we’re inspiring global progress in clinical research and practice.

Each of these projects exemplifies our commitment to disruptive, forward-thinking research.

See how We transform health outcomes

Engaging

We shine by illuminating disparities, identifying solutions, and connecting with our communities to address barriers and improve care for all

Throughout 2022, DCRI research teams continued to shine the light on the systems and biases that create health disparities. We created frameworks to eliminate barriers to equity in care, and engaged our communities to improve access to quality health care for all.

Learn howWe’re engaging our communities

Reimagining

We shine by bending the arc of research toward new systems that significantly improve healthcare

DCRI is leading clinical research into a future where healthcare is more accessible, equitable, and effective by prioritizing innovation and championing disruptive ideas. We’re systematically evaluating and improving the technologies that create new opportunities for optimizing healthcare.

Find out What’s next for the DCRI

DCRI at a glance

A pie chart showing a breakdown of projects by study phase at DCRI. It shows 2% phase 1, 21% phase 2, 39% phase 3, 10% phase 4, 10% Registry, 6% Thought Leadership, 6% project leadership, 6% other.

A pie chart showing projects by therapeutic area. It shows 39% cardiovascular, 10% medicine plus, 2% musculoskeletal and surgical sciences, 41% pediatrics, 5% population health sciences.

A pie chart showing projects by study size. It shows 21% megatrials, 24% large trials, 15% medium trials, 40% small trials.

A pie chart showing projects by study population. It shows 2% Adolescent, 59% adult, 4% geriatric, 32% Pediatric & Pre/Neo-natal, and 3% n/a.

DCRI U.S. Participating Sites

The Duke Clinical Research Institute site network stretches across the United States. We have more than than 1,600 sites in our national site network, and partnered with more than 10,000 U.S. sites in 2022.